RadNet Reports Full-Year 2025 Net Loss for Common Stockholders Despite Record Revenue and Adjusted EBITDA

summarizeSummary

RadNet reported a net loss of $(18.652) million for common stockholders in 2025, despite achieving record revenue and Adjusted EBITDA, reflecting significant investments in acquisitions and its Digital Health segment. Several key executives also received substantial salary increases and new titles.

check_boxKey Events

• Shift to Net Loss for Common Stockholders

  RadNet reported a net loss of $(18.652) million attributable to common stockholders for the full year 2025, a significant decline from a net income of $2.793 million in 2024.

• Record Revenue and Adjusted EBITDA Growth

  The company achieved record total revenue of $2.040 billion in 2025, an 11.5% increase year-over-year, and Adjusted EBITDA grew by 7.4% to $300.221 million, indicating strong operational performance despite the net loss.

• Aggressive Acquisition Strategy Continues

  RadNet completed multiple acquisitions in 2025, including iCAD, Inc. for $110.7 million (all-stock), See-Mode Technologies for $28.9 million, and CIMAR UK Limited for $37.0 million. Subsequent to year-end, the company announced the acquisition of Gleamer SAS for approximately €230 million (~$250 million) on March 2, 2026, alongside other smaller acquisitions.

• Digital Health Segment Expansion and Losses

  The Digital Health segment's revenue surged by 41.1% to $92.7 million in 2025, but its operating loss widened to $(32.297) million, reflecting substantial investments in AI technologies and integration costs from recent acquisitions.

auto_awesomeAnalysis

RadNet's annual report for 2025 reveals a significant shift to a net loss attributable to common stockholders of $(18.652) million, a notable reversal from a $2.793 million profit in 2024. This bottom-line decline occurred despite the company achieving record total revenue of $2.040 billion (up 11.5%) and a 7.4% increase in Adjusted EBITDA to $300.221 million. The net loss is primarily driven by substantial investments in acquisitions and the Digital Health segment, which, while growing revenue by 41.1%, continues to operate at an increased loss. The company also detailed several executive compensation increases and title changes, effective January 1, 2026, for key personnel including the CFO and Presidents of operations, signaling a commitment to talent amidst strategic expansion. Investors should closely monitor the profitability of the Digital Health segment and the integration of recent and upcoming acquisitions, such as Gleamer SAS, to assess the long-term impact on the company's financial health.